According to the FDA-approved prescribing information for Wegovy (semaglutide, current label on file with the FDA as of 2026) and Zepbound (tirzepatide, current label on file with the FDA as of 2026), both carry these warnings: A boxed warning - the FDA's most serious warning category - for thyroid C-cell tumors observed in rodent studies
Thoroughly clean about two inches of skin with a fresh alcohol pad and let it air dry completely
3.	Ali M
The next wave of incretin-based therapies is poised to offer significant advantages over the current generation for treating diabetics and for weight loss in those living with obesity
Furthermore, they also found that 'a balanced dual agonist in mice engineered to lack GLP-1 receptors still induced weight loss, proving that the compounds were not causing weight loss purely by targeting GLP-1' (Molteni, Chen)
If you are planning pregnancy, discuss with your doctor the need to stop treatment beforehand (at least 2 months before conception for semaglutide)